| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/30/2006 | CN1823793A Atfuweibi terveleryl oxo methyl ester enteric micropill and its preparation method |
| 08/30/2006 | CN1823790A Preparation method of bacteriostatic agent sulfadiazine cerium |
| 08/30/2006 | CN1823783A Preparation method of cephapian aseptic mixed powder injection agent |
| 08/30/2006 | CN1823782A Long effect oxyfluoroshaxin nano-capsule injection liquid for animal and its preparation method |
| 08/30/2006 | CN1823761A Yiganling dispersion tablet for treating liver disease and its preparation method |
| 08/30/2006 | CN1823753A Cream for treating beriberi and its production method |
| 08/30/2006 | CN1823738A Powder ampoule agent for injection and its preparation method |
| 08/30/2006 | CN1272436C Synthesis and high-efficiency expression method of bivalent foot-and-mouth disease polypeptide vaccine |
| 08/30/2006 | CN1272342C Novel process for preparing recombinaant CHO cell hepatitis B vaccine |
| 08/30/2006 | CN1272340C Oleanolic acid couple derivatives and their pharmaceutical use |
| 08/30/2006 | CN1272327C Preparation method for sulfadoxine |
| 08/30/2006 | CN1272290C Capejasmine cycloolefines ether terpene extract and its preparation method and use |
| 08/30/2006 | CN1272061C Chinese medicine for treating acute appendicitis and chronic appendicitis, preparing method thereof |
| 08/30/2006 | CN1272053C Chinese medicine for treating tuberculosis and its prepn and use |
| 08/30/2006 | CN1272045C Wolfberry fruit-astragalus root oral liquid and its prepn process |
| 08/30/2006 | CN1272043C External used medicine for inhibiting fungus and its preparation |
| 08/30/2006 | CN1272041C Medicine for treating dermatosis and its preparation method |
| 08/30/2006 | CN1272028C Antiviral compound Chinese medicine and its prepn |
| 08/30/2006 | CN1272024C Use of dietary additives for preparing medicament for treating malignancies and viral infections and improving immunologic function |
| 08/30/2006 | CN1272020C Composition of hypochlorous acid and its applications |
| 08/30/2006 | CN1272015C Adefovir dipivoxil and polyethylene glycol fused matter and its preparation method |
| 08/30/2006 | CN1272012C Dermatopathy therapeutic medicine compositions and its preparation method |
| 08/30/2006 | CN1272009C Freeze dried preparation of diammonium glycyrrhizinate and its preparation |
| 08/30/2006 | CN1272003C Sophocarpidine gel preparation and its preparation |
| 08/29/2006 | US7098334 Inhibitors of 5'-methylthioadenosine phosphorylase (MTAP) and 5'-methylthioadenosine nucleosidase (MTAN); treating cancer, malaria, bacterial infections; (1S)-1-(9-deazaadenin-9-yl)-1,4,5-trideoxy-1,4-imino-D-ribitol for example |
| 08/29/2006 | US7098330 Pyrazolylamine substituted quinazoline compounds useful as protein kinase inhibitors |
| 08/29/2006 | US7098303 Immunogenic polypeptide; vaccine for therapy of HCV infection and assays for the diagnosis of HCV |
| 08/29/2006 | US7098239 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 08/29/2006 | US7098231 Viral polymerase inhibitors |
| 08/29/2006 | US7098215 Nitrogenous compounds and antiviral drugs containing the same |
| 08/29/2006 | US7098213 three-ring saturated N-heterocyclic compounds in combination with one or more antiviral or other agents; in immunotherapy |
| 08/29/2006 | US7098212 Piperazine derivatives |
| 08/29/2006 | US7098202 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 08/29/2006 | US7098201 Heteroaromatic derivatives having an inhibitory activity against HIV integrase |
| 08/29/2006 | US7098197 An antiviral nucleoside in which the 5'-hydroxyl group has been substituted for a phosphonate or methyl phosphonate that is covalently linked to an alkylethanediol; osteoporosis; anticarcinogenic agents; viricides |
| 08/29/2006 | US7098184 Comprises ligand polypeptide for treatment of viral infection and prevention of immunological response; immunosuppressants; genetic vaccines |
| 08/29/2006 | US7097994 UDP-N-acetylglucosamine:galactose-β1,3-N-acetylgalactosamine-α-R/ (GlcNAc to GaINAc) β1-6 N-acetylglucosaminyltransferase, C2GnT3 |
| 08/29/2006 | US7097987 Hepatitis C receptor protein CD81 |
| 08/29/2006 | US7097985 for the treatment of leukemia, tumors, chronic infections, autoimmune disease, fibrotic disorders, wound healing and psoriasis |
| 08/29/2006 | US7097971 novel peptides based on conserved regions of regulatory and auxiliary HIV proteins, antigens in free or carrier-bound form comprising one of the peptides, vaccine compositions containing one of the antigens, immunoassay kits and a method of detecting antibodies, induced by HIV using such antigens |
| 08/29/2006 | US7097851 Multilayer capsule comprises an adhesion site-controlling layer for attaching to a selected site in the intestines, a drug-carrying layer, a protecting layer for preventing from digestive juice; improve bioavailability due to a low absorption in the digestive tract; dosage forms |
| 08/29/2006 | US7097843 Immunogenic peptides from the HPV E7 protein |
| 08/29/2006 | US7097838 Antagonists of HMG1 for treating inflammatory conditions |
| 08/29/2006 | US7097823 Administering a RADIONUCLIDE COMPLEXED WITH A CHELATING AGENT SUCH AS MACROCYCLIC AMINOPHOSPHONIC ACID, or tetraazacyclododecanetetramethylenephosphonic acid (DOTMP); osteomyelitis treatment |
| 08/29/2006 | CA2402020C Pharmaceutical compositions |
| 08/29/2006 | CA2392271C Sulfonyl heteroaryl triazoles as anti-inflammatory/analgesic agents |
| 08/29/2006 | CA2318851C Recombinant human mannan-binding proteins and process for producing the same |
| 08/29/2006 | CA2314934C Use of microparticles combined with submicron oil-in-water emulsions |
| 08/29/2006 | CA2258152C Novel aromatic derivatives substituted by a ribose, their method of preparation and application as medicine |
| 08/29/2006 | CA2187974C Newcastle disease virus combination vaccine |
| 08/29/2006 | CA2112779C Arylsulfonamido-substituted hydroxamic acids |
| 08/29/2006 | CA2053585C Antibody production in chinese hamster ovary cells |
| 08/24/2006 | WO2006089054A1 New isothiazoloquinolones and related compounds as anti-infective agents |
| 08/24/2006 | WO2006088920A1 Amine-linked pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity |
| 08/24/2006 | WO2006088840A1 Novel heterocyclic substituted pyridine or phenyl compounds with cxcr3 antagonist activity |
| 08/24/2006 | WO2006088790A2 Use of chlorine dioxide for the treatment of onychomycosis (nail fungus) |
| 08/24/2006 | WO2006088191A1 Eudistomin derivative |
| 08/24/2006 | WO2006088173A1 Bicyclic carbamoylpyridone derivative having hiv integrase inhibiting activity |
| 08/24/2006 | WO2006088010A1 Antimicrobial peptide and use thereof |
| 08/24/2006 | WO2006087548A2 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors |
| 08/24/2006 | WO2006087387A1 Hiv inhibiting 2-(4-cyanophenylamino) pyrimidine oxide derivatives |
| 08/24/2006 | WO2006087135A1 Tetrazine derivatives having an antimycotic effect, and use thereof |
| 08/24/2006 | WO2006087077A2 Hsp90-inhibiting triazole derivatives |
| 08/24/2006 | WO2006086888A1 Compositions for treatment of diseases of the nail unit |
| 08/24/2006 | WO2006086865A2 Combi-preparation of nucleoside and non-nucleoside reverse transcriptase inhibitors for the treatment of hiv infections |
| 08/24/2006 | WO2006086823A1 Molecules and chimeric molecules thereof |
| 08/24/2006 | WO2006067635A3 USE OF Ϝδ T LYMPHOCYTE ACTIVATORS AS VACCINE ADJUVANT |
| 08/24/2006 | WO2006061714A3 Anticoronaviral compounds and compositions, their pharmaceutical uses and materials for their synthesis |
| 08/24/2006 | WO2006053323A3 Inhibitors of hiv-1 capsid formation: substituted aryl aminomethyl thiazole ureas and analogues thereof |
| 08/24/2006 | WO2006039545A3 Use of parp-1 inhibitors for protecting tumorcidal lymphocytes from apoptosis |
| 08/24/2006 | WO2006035067A3 Hiv inhibiting 5-heterocyclyl pyrimidines |
| 08/24/2006 | WO2006019955A3 Antiviral methods and compositions |
| 08/24/2006 | WO2005116002B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| 08/24/2006 | WO2004069134A8 Invert emulsion type composition containing at least one active agent sensitive to the presence of water, and its uses in cosmetics and in dermatology |
| 08/24/2006 | WO2003070193A3 RNA interference mediated inhibition of HIV gene expression using short interfering nucleic acid (siNA) |
| 08/24/2006 | US20060191024 Method for preparing anti-MIF antibodies |
| 08/24/2006 | US20060189810 Novel sulfonamide inhibitors of aspartyl protease |
| 08/24/2006 | US20060189792 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies |
| 08/24/2006 | US20060189699 Antimicrobial trinervitane derivatives |
| 08/24/2006 | US20060189688 Use of sodium 2-mercaptoethanesulfonate as antiviral agent |
| 08/24/2006 | US20060189681 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
| 08/24/2006 | US20060189672 2-Heterocyclyl- indole, pyrrolopyridine, pyrrolopyrimidine, or pyrrolopirazine substituted with an N-(amino)sulfonyl(thio)carboxamide: 3-Cyclohexyl-2-furan-3-yl-7-methyl-1H-indole-6-(N-methylsulfonyl)carboxamide; treating a hepatitis virus infection |
| 08/24/2006 | US20060189665 Oxamide derivatives useful as raf-kinase inhibitors |
| 08/24/2006 | US20060189656 Piperidine derivatives and agent comprising the derivative as active ingredient |
| 08/24/2006 | US20060189652 7-oxo-6-(sulphooxy)-1,6-diazabicyclo[3,2,1]octane-2-carboxamide; reacting nitrogen heterocyclic compound with carbonylation agent selected from phosgene, diphosgene, triphosgene, aryl chloroformates, aralkyl chloroformates, alkyl chloroformates, cyclization |
| 08/24/2006 | US20060189614 preparing 4-[[4-amino-6-[(2,6-dichlorophenyl)methyl]-1,3,5-triazin-2-yl]amino]benzonitrile by reacting 2,6-dichlorobenzeneethanimidamide with phenyl N'-cyano-N-(4-cyanophenyl)-carbamimidate in a reaction-inert solvent; HIV (Human Immunodeficiency Virus) infection |
| 08/24/2006 | US20060189611 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 08/24/2006 | US20060189604 Gramnegative and Grampositive bacterial infections; substituted Piperidine derivatives specially optionally substituted pyrido [3,2, -b][1,4] thiazin-yl; 6-({(3R,4S)-3-Fluoro-1-[(R)-2-hydroxy-2-(2-methoxy-quinolin-8-yl)-ethyl]-piperidin-4-ylamino }-methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one; nontoxic |
| 08/24/2006 | US20060189592 Crystal of 1-methylcarbapenem compound |
| 08/24/2006 | US20060189565 Pharmaceutical compositions of ganciclovir |
| 08/24/2006 | US20060189550 Immunostimulatory, Covalently lipidated oligonucleotides |
| 08/24/2006 | US20060189542 Preventive or therapeutic composition for viral infectious disease |
| 08/24/2006 | US20060189538 Peptides and nucleic acids of the cathelicidin family, derived from fish, and uses thereof |
| 08/24/2006 | US20060189517 Cross-linked glycopeptide-cephalosporin antibiotics |
| 08/24/2006 | US20060189500 Aqueous olanexidine solution, method of preparing the same, and disinfectant |
| 08/24/2006 | US20060189483 Metal-containing compositions, preparations and uses |
| 08/24/2006 | US20060188963 Collectin-complement activating protein chimeras |
| 08/24/2006 | US20060188923 Novel human parvovirus B19 receptor and uses thereof |
| 08/24/2006 | US20060188920 Identification of compounds that inhibit replication of human immunodeficiency virus |
| 08/24/2006 | US20060188913 Methods and products for enhancing immune responses using imidazoquinoline compounds |